BLRX
Price
$4.43
Change
+$0.03 (+0.68%)
Updated
Jun 27 closing price
Capitalization
17.11M
KURA
Price
$5.67
Change
-$0.06 (-1.05%)
Updated
Jun 27 closing price
Capitalization
490.88M
31 days until earnings call
Interact to see
Advertisement

BLRX vs KURA

Header iconBLRX vs KURA Comparison
Open Charts BLRX vs KURABanner chart's image
BioLineRx
Price$4.43
Change+$0.03 (+0.68%)
Volume$52.31K
Capitalization17.11M
Kura Oncology
Price$5.67
Change-$0.06 (-1.05%)
Volume$3.33M
Capitalization490.88M
BLRX vs KURA Comparison Chart in %
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. KURA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Buy and KURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BLRX: $4.43 vs. KURA: $5.67)
Brand notoriety: BLRX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 6% vs. KURA: 280%
Market capitalization -- BLRX: $17.11M vs. KURA: $490.88M
BLRX [@Biotechnology] is valued at $17.11M. KURA’s [@Biotechnology] market capitalization is $490.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 2 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • BLRX’s TA Score: 2 bullish, 5 bearish.
  • KURA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both BLRX and KURA are a bad buy in the short-term.

Price Growth

BLRX (@Biotechnology) experienced а +4.48% price change this week, while KURA (@Biotechnology) price change was -3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($491M) has a higher market cap than BLRX($17.1M). KURA YTD gains are higher at: -34.902 vs. BLRX (-48.248). BLRX has higher annual earnings (EBITDA): 8.5M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. BLRX (26.4M). BLRX has less debt than KURA: BLRX (13.7M) vs KURA (19.4M). KURA has higher revenues than BLRX: KURA (68M) vs BLRX (22.3M).
BLRXKURABLRX / KURA
Capitalization17.1M491M3%
EBITDA8.5M-177.18M-5%
Gain YTD-48.248-34.902138%
P/E RatioN/AN/A-
Revenue22.3M68M33%
Total Cash26.4M658M4%
Total Debt13.7M19.4M71%
FUNDAMENTALS RATINGS
BLRX vs KURA: Fundamental Ratings
BLRX
KURA
OUTLOOK RATING
1..100
5070
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
5865
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLRX's Valuation (16) in the Pharmaceuticals Other industry is in the same range as KURA (24) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as KURA (100) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as KURA (97) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's Price Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as KURA (65) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as KURA (100) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXKURA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BDAFX30.190.29
+0.97%
Baron Durable Advantage Retail
JIESX17.810.15
+0.85%
JPMorgan Developed International Value I
FDECX22.750.17
+0.75%
Fidelity Advisor Capital Development C
SUGAX13.670.07
+0.51%
Victory Pioneer Global Growth A
BUIMX17.190.08
+0.47%
Buffalo Mid Cap Growth Inst

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
+0.68%
PYXS - BLRX
42%
Loosely correlated
-6.78%
KURA - BLRX
36%
Loosely correlated
-1.05%
INSM - BLRX
30%
Poorly correlated
-5.11%
AEON - BLRX
29%
Poorly correlated
+0.80%
MRKR - BLRX
27%
Poorly correlated
N/A
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-1.05%
PYXS - KURA
65%
Loosely correlated
-6.78%
OPORF - KURA
62%
Loosely correlated
N/A
KYMR - KURA
44%
Loosely correlated
-3.48%
ZYME - KURA
44%
Loosely correlated
+0.81%
ADVM - KURA
42%
Loosely correlated
-6.83%
More